CIK: 0001831942
Total reported value
$1.7B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Merus N V | Stock-Other | 16.20% | — | — | |
| 2 | NUVL | Nuvalent Inc-a | Stock-Other | 5.91% | +1.26% | +1.82% | |
| 3 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 5.29% | -2.59% | -10.74% | |
| 4 | COGT | Cogent Biosciences INC | Stock-Other | 5.08% | +1.24% | +213.69% | |
| 5 | ELVN | Enliven Therapeutics INC | Stock-Other | 4.69% | +2.62% | — | |
| 6 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 4.58% | — | +0.57% | |
| 7 | ALKS | Alkermes plc | Stock-Healthcare | 4.54% | +1.98% | +26.40% | |
| 8 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 4.46% | -2.44% | +121.31% | |
| 9 | RLAY | Relay Therapeutics INC | Stock-Other | 4.33% | +0.22% | +27.34% | |
| 10 | CLDX | Celldex Therapeutics INC | Stock-Other | 3.82% | +0.31% | -12.22% | |
| 11 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 3.37% | -1.66% | EXIT | |
| 12 | VRDN | Viridian Therapeutics INC | Stock-Other | 3.37% | — | -34.36% | |
| 13 | PTGX | Protagonist Therapeutics INC | Stock-Other | 3.32% | -2.62% | EXIT | |
| 14 | PHVS | Pharvaris N.V. | Stock-Other | 2.95% | -0.35% | +26.53% | |
| 15 | CDTX | Cidara Therapeutics INC | Stock-Other | 2.73% | — | -50.21% | |
| 16 | AMLX | Amylyx Pharmaceuticals INC | Stock-Other | 2.70% | — | — | |
| 17 | TYRA | Tyra Biosciences INC | Stock-Other | 2.30% | -0.43% | +8.87% | |
| 18 | 430 | Terns Pharmaceuticals INC | Stock-Other | 2.09% | -3.97% | EXIT | |
| 19 | KYMR | Kymera Therapeutics INC | Stock-Other | 2.07% | -0.27% | — | |
| 20 | BRD1EUR | Mind Medicine Mindmed INC | Stock-Other | 1.86% | -1.78% | EXIT | |
| 21 | NRIX | Nurix Therapeutics INC | Stock-Other | 1.71% | -0.83% | -4.27% | |
| 22 | ORKA | Oruka Therapeutics INC | Stock-Other | 1.65% | -3.54% | EXIT | |
| 23 | SYRE | Spyre Therapeutics INC | Stock-Other | 1.63% | +0.37% | — | |
| 24 | DRUG | Bright Minds Biosciences INC | Stock-Other | 1.48% | -0.10% | EXIT | |
| 25 | ASMB | Assembly Biosciences INC | Stock-Other | 1.25% | -0.65% | — | |
| 26 | CTMX | Cytomx Therapeutics INC | Stock-Other | 1.20% | -2.18% | EXIT | |
| 27 | LBRX | Lb Pharmaceuticals INC | Stock-Other | 1.16% | -0.08% | — | |
| 28 | TNGX | Tango Therapeutics INC | Stock-Other | 0.62% | — | — | |
| 29 | APGE | Apogee Therapeutics INC | Stock-Other | 0.56% | — | — | |
| 30 | PEPG | Pepgen INC | Stock-Other | 0.53% | -1.01% | — | |
| 31 | ENTA | Enanta Pharmaceuticals INC | Stock-Other | 0.47% | — | — | |
| 32 | SABS | Sab Biotherapeutics INC | Stock-Other | 0.43% | -0.12% | — | |
| 33 | IKT | Inhibikase Therapeutics INC | Stock-Other | 0.43% | -0.22% | — | |
| 34 | ✓ | Stock-Other | 0.39% | — | — | ||
| 35 | AVTX | Avalo Therapeutics INC | Stock-Other | 0.30% | -0.16% | — | |
| 36 | VTGN | Vistagen Therapeutics INC | Stock-Other | 0.27% | — | — | |
| 37 | ✓ | Crescent Biopharma INC. | Stock-Other | 0.26% | — | -0.63% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Merus N V | +2.3% | — | Trim |
| 2 | TYRA | Tyra Biosciences INC | +1.7% | +8.87% | Add |
| 3 | COGT | Cogent Biosciences INC | +1.2% | +213.69% | Trim |
| 4 | 260 | Centessa Pharmaceuticals-adr | +0.9% | -13.59% | Add |
| 5 | PHVS | Pharvaris N.V. | +0.7% | +26.53% | Add |
| 6 | ORKA | Oruka Therapeutics INC | +0.6% | +23.48% | Add |
| 7 | DRUG | Bright Minds Biosciences INC | +0.2% | — | Unchanged |
| 8 | AVTX | Avalo Therapeutics INC | 0% | — | Unchanged |
| 9 | VTGN | Vistagen Therapeutics INC | 0% | — | Unchanged |
| 10 | BRD1EUR | Mind Medicine Mindmed INC | -0.1% | -35.50% | Trim |
| 11 | AGIO | Agios Pharmaceuticals INC | -0.1% | +0.57% | Add |
| 12 | ✓ | -0.2% | — | Unchanged | |
| 13 | ALKS | Alkermes plc | -0.2% | +26.40% | Add |
| 14 | VRDN | Viridian Therapeutics INC | -0.2% | -34.36% | Trim |
| 15 | APGE | Apogee Therapeutics INC | -0.2% | — | Unchanged |
| 16 | IKT | Inhibikase Therapeutics INC | -0.4% | — | Add |
| 17 | XENE | Xenon Pharmaceuticals INC | -0.5% | -10.74% | Add |
| 18 | CLDX | Celldex Therapeutics INC | -0.5% | -12.22% | Trim |
| 19 | SYRE | Spyre Therapeutics INC | -0.7% | — | Unchanged |
| 20 | SLNOEUR | Soleno Therapeutics INC | -1.6% | +121.31% | Add |
| 21 | NRIX | Nurix Therapeutics INC | -1.8% | -4.27% | Trim |
| 22 | ELVN | Enliven Therapeutics INC | -2.1% | — | Add |
| 23 | NUVL | Nuvalent Inc-a | -3.8% | +1.82% | Trim |
| 24 | RLAY | Relay Therapeutics INC | — | NEW | New buy |
| 25 | PTGX | Protagonist Therapeutics INC | — | NEW | New buy |
| 26 | PCVX | Vaxcyte INC | — | EXIT | Sold out |
| 27 | VERA | Vera Therapeutics INC | — | EXIT | Sold out |
| 28 | SRRK | Scholar Rock Holding CORP | — | EXIT | Sold out |
| 29 | CDTX | Cidara Therapeutics INC | — | NEW | New buy |
| 30 | AMLX | Amylyx Pharmaceuticals INC | — | NEW | New buy |
| 31 | 430 | Terns Pharmaceuticals INC | — | NEW | New buy |
| 32 | KYMR | Kymera Therapeutics INC | — | NEW | New buy |
| 33 | ASMB | Assembly Biosciences INC | — | NEW | New buy |
| 34 | CTMX | Cytomx Therapeutics INC | — | NEW | New buy |
| 35 | LBRX | Lb Pharmaceuticals INC | — | NEW | New buy |
| 36 | SLDB | Solid Biosciences INC | — | EXIT | Sold out |
| 37 | CRDF | Cardiff Oncology INC | — | EXIT | Sold out |
| 38 | TNGX | Tango Therapeutics INC | — | NEW | New buy |
| 39 | ORIC | Oric Pharmaceuticals INC | — | EXIT | Sold out |
| 40 | PEPG | Pepgen INC | — | NEW | New buy |
| 41 | NGNE | Neurogene INC | — | EXIT | Sold out |
| 42 | ENTA | Enanta Pharmaceuticals INC | — | NEW | New buy |
| 43 | SABS | Sab Biotherapeutics INC | — | NEW | New buy |
| 44 | CELC | Celcuity INC | — | EXIT | Sold out |
| 45 | ✓ | Crescent Biopharma INC. | — | NEW | New buy |